Haverford Trust Co. lowered its holdings in Clorox Company (The) (NYSE:CLX) by 11.4% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,681 shares of the company’s stock after selling 475 shares during the period. Haverford Trust Co.’s holdings in Clorox Company (The) were worth $486,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Janus Henderson Group PLC increased its stake in shares of Clorox Company (The) by 8,008.5% in the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock valued at $176,340,000 after purchasing an additional 1,307,153 shares during the period. Vanguard Group Inc. increased its stake in shares of Clorox Company (The) by 2.6% in the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after purchasing an additional 369,918 shares during the period. APG Asset Management N.V. increased its stake in shares of Clorox Company (The) by 30.9% in the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock valued at $171,736,000 after purchasing an additional 307,700 shares during the period. Ameriprise Financial Inc. increased its stake in shares of Clorox Company (The) by 24.6% in the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after purchasing an additional 265,200 shares during the period. Finally, Renaissance Technologies LLC increased its stake in shares of Clorox Company (The) by 24.5% in the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after purchasing an additional 263,700 shares during the period. 72.74% of the stock is currently owned by hedge funds and other institutional investors.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of Clorox Company (The) stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Matthew T. Laszlo sold 20,051 shares of Clorox Company (The) stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares in the company, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Haverford Trust Co. Sells 475 Shares of Clorox Company (The) (CLX)” was reported by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://www.watchlistnews.com/haverford-trust-co-sells-475-shares-of-clorox-company-the-clx/1723598.html.

CLX has been the topic of several analyst reports. BMO Capital Markets restated a “buy” rating and issued a $150.00 price target on shares of Clorox Company (The) in a research note on Thursday, October 5th. Barclays PLC reiterated an “equal weight” rating and set a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Morgan Stanley lowered their price objective on shares of Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 2nd. Jefferies Group LLC reiterated a “hold” rating and set a $132.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, November 1st. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research note on Sunday, October 8th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $128.72.

Clorox Company (NYSE:CLX) opened at $134.95 on Friday. Clorox Company has a 12 month low of $112.28 and a 12 month high of $141.76. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. The company has a market cap of $17,400.26, a P/E ratio of 24.32, a P/E/G ratio of 3.68 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.05. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter last year, the business earned $1.36 earnings per share. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. research analysts expect that Clorox Company will post 5.58 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a yield of 2.49%. Clorox Company (The)’s dividend payout ratio (DPR) is 61.88%.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.